These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10664629)

  • 1. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
    Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
    Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
    Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
    Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
    Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
    Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
    Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
    Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.
    Kim JH; Park JM; Jung CW; Park SS; Kim SJ; Mok YJ; Kim CS; Chae YS; Bae JW
    J Surg Oncol; 2008 Feb; 97(2):125-30. PubMed ID: 18095267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
    Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
    Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine motility factor receptor: a clinical review.
    Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
    Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
    J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
    Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM
    Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motility- and adhesion factors in bladder carcinoma.
    Otto T; Goepel M; Enzwi SM; Meyer-Schwickerath M; Rübben H
    Investig Urol (Berl); 1994; 5():80-4. PubMed ID: 7719326
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
    Otto T; Birchmeier W; Schmidt U; Hinke A; Schipper J; Rübben H; Raz A
    Cancer Res; 1994 Jun; 54(12):3120-3. PubMed ID: 8205527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
    Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
    Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
    Jiang WG; Raz A; Douglas-Jones A; Mansel RE
    J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.